To answer these questions, we examined and compared circulating CD4+ T cell subsets (Th1, Th2, Th17, Tregs, Th10, and CD4+α-7+ T cells) in healthy nonsmokers, patients with stable COPD, and patients with acute exacerbation in COPD. This evidence concerns the gene CD4 and chronic obstructive pulmonary disease.